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Background: Antibiotic resistance is rising to dangerous levels. New resistance mechanisms are 
reported every year, threatening the ability to control infectious diseases with available antimicrobial 
therapies. The characterization of the antibiotic resistance gene pool is therefore crutial for an 
accurate monitoring and control of high resistant bacteria. 
Objectives: The objective of this study was to identify the genes associated with the production of 
carbapenemases, extended-spectrum -lactamases (ESBL) and/or AmpC -lactamases in a collection 
of gram-negative isolates from a central hospital in the northern region of Portugal. 
Methods: Primers to amplify clinically relevant resistance genes were selected from the literature: 
blaKPC, blaIMP, blaVIM, blaOXA-48, blaOXA-23, blaNDM, blaSHV, blaTEM, blaCTX-M, blaCMY-2 and 
blaDHA. Two multiplex PCR sets were designed for the detection of carbapenemases, one for the 
ESBL and one for the AmpC -lactamases. All assays were validated using 22 control strains 
containing characterized resistance genes. Subsequently, a set of 52 clinical isolates with antibiotic 
resistance were evaluated. 
Results: PCR screening identified 13 (25.0%) isolates positives for carbapenemases genes. Of those, 4 
(7.7%), including three Klebsiella pneumoniae and one Escherichia coli, were positive for blaKPC and 
9 (17.3%) Acinetobacter baumannii were positive for blaOXA-23. ESBL genes were the most 
prevalent: 14 (26.9%) isolates were positive for blaSHV, 17 (32.7%) for blaCTX-M and 15 (28.8%) for 
blaTEM. For AmpC -lactamases only 7 Enterobacteriaceae isolates were found positive for blaCMY-2 
or blaDHA. Fourteen (26.9%) isolates did not contain any of the tested genes and 18 (34.6%) isolates 
contained two or more resistance genes. 
 
 
 
 
